DiaMedica Therapeutics, Inc. (DMAC)
7.26
+0.41
(+5.99%)
USD |
NASDAQ |
Sep 21, 16:00
7.26
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Price : 7.26 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 6.85 | 6.94 | 6.755 | 6.85 | 194956.0 |
| Sep 17, 2026 | 6.75 | 7.00 | 6.675 | 6.85 | 257771.0 |
| Sep 16, 2026 | 6.55 | 6.74 | 6.46 | 6.63 | 187273.0 |
| Sep 15, 2026 | 6.55 | 6.65 | 6.36 | 6.53 | 157943.0 |
| Sep 14, 2026 | 6.49 | 6.65 | 6.44 | 6.55 | 145606.0 |
| Sep 11, 2026 | 6.57 | 6.877 | 6.33 | 6.47 | 123613.0 |
| Sep 10, 2026 | 6.57 | 6.665 | 6.30 | 6.47 | 182443.0 |
| Sep 09, 2026 | 6.50 | 6.974 | 6.50 | 6.59 | 167128.0 |
| Sep 08, 2026 | 6.70 | 6.71 | 6.53 | 6.54 | 119063.0 |
| Sep 04, 2026 | 6.56 | 6.887 | 6.49 | 6.75 | 189481.0 |
| Sep 03, 2026 | 6.78 | 6.79 | 6.525 | 6.56 | 116144.0 |
| Sep 02, 2026 | 6.60 | 6.935 | 6.59 | 6.75 | 175978.0 |
| Sep 01, 2026 | 6.29 | 6.45 | 6.265 | 6.45 | 145931.0 |
| Aug 31, 2026 | 6.44 | 6.59 | 6.22 | 6.35 | 135124.0 |
| Aug 28, 2026 | 6.72 | 6.74 | 6.34 | 6.39 | 116507.0 |
| Aug 27, 2026 | 6.68 | 6.80 | 6.56 | 6.75 | 113812.0 |
| Aug 26, 2026 | 6.66 | 6.76 | 6.62 | 6.70 | 118271.0 |
| Aug 25, 2026 | 6.60 | 6.865 | 6.60 | 6.74 | 130949.0 |
| Aug 24, 2026 | 6.53 | 6.57 | 6.32 | 6.52 | 85655.00 |
| Aug 21, 2026 | 6.58 | 6.73 | 6.50 | 6.52 | 77579.00 |
| Aug 20, 2026 | 6.77 | 6.90 | 6.42 | 6.52 | 130870.0 |
| Aug 19, 2026 | 6.74 | 6.91 | 6.66 | 6.81 | 170192.0 |
| Aug 18, 2026 | 6.52 | 6.66 | 6.48 | 6.61 | 68933.00 |
| Aug 17, 2026 | 6.67 | 6.776 | 6.56 | 6.62 | 122972.0 |
| Aug 14, 2026 | 6.74 | 6.785 | 6.55 | 6.68 | 165178.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.40 |
| Alnylam Pharmaceuticals, Inc. | 244.24 |
| Anika Therapeutics, Inc. | 20.72 |
| Savara, Inc. | 5.455 |
| Vericel Corp. | 39.53 |
Price Related Metrics
| PEG Ratio | -2.962 |
| Price to Book Value | 10.21 |
| Earnings Yield | -9.83% |
| Market Cap | 391.50M |
| PEGY Ratio | -2.962 |